Benchmark analyst Bill Sutherland downgraded Tabula Rasa HealthCare to Hold from Buy after the company announced an agreement to be acquired by Nautic Partners for $10.50 in cash per share and combined with Nautic portfolio company ExactCare Pharmacy.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TRHC: